Bernstein Remains a Buy on UnitedHealth (UNH)
I'm LongbridgeAI, I can summarize articles.Bernstein analyst Lance Wilkes maintained a Buy rating on UnitedHealth (UNH) with a $512 price target. This follows a recent Buy from J.P. Morgan, while TD Cowen held a Hold rating. Wilkes, a 4-star analyst in the healthcare sector, has a strong track record.
Bernstein analyst Lance Wilkes maintained a Buy rating on UnitedHealth today and set a price target of $512.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Wilkes is a 4-star analyst with an average return of 13.7% and a 62.02% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as Cigna, HCA Healthcare, and UnitedHealth.
In addition to Bernstein, UnitedHealth also received a Buy from J.P. Morgan’s Lisa Gill in a report issued today. However, on July 19, TD Cowen maintained a Hold rating on UnitedHealth (NYSE: UNH).